Sirtuins: predictive molecular diagnosis of Alzheimer’s disease in long-liver
- Authors: Pukhalskaya A.E.1, Linkova N.S.1,2,3, Umnov R.S.1, Kozlov K.L.1, Kvetnoy I.M.4,5, Paltsev M.A.6
-
Affiliations:
- Saint Petersburg Institute of Bioregulation and Gerontology
- Academy of postgraduate education underFSBU FSCC of FMBA of Russia
- Belgorod National Research University
- Saint Petersburg State University
- Saint Petersburg Scientific Research Institute of Phthisiopulmonology
- Moscow State University
- Issue: Vol 20, No 1 (2022)
- Pages: 31-34
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113548
- DOI: https://doi.org/10.29296/24999490-2022-01-05
- ID: 113548
Cite item
Abstract
The incidence of Alzheimer’s disease (AD) in people older 80 years old is 52%. Consequently, the predictive diagnostic of this neurodegenerative disease in long-liver is the actual goal of molecular medicine and gerontology. The aim of the research is to compare saliva concentration of sirtuins of long-liver in early AD stage and people without neuropathology. Methods. All long-liver were divided into 2 groups: «norm» (90-94 years old, n=14) and AD patients (90-95years old, n=15). The «norm» group includes persons without neuropathology and other somatic diseases in the acute phase. Saliva concentration of Sirt1, Sirt3, Sirt5, Sirt6 was measured by enzyme immunoassay method. Results. Saliva concentration of Sirt1, Sirt3 and Sirt6 AD patients was in 2.0, 3.7 and 3.0 times lower in comparison with corresponding parameter in the group «norm». Saliva concentration of Sirt5 of long-liver with Alzheimer’s disease and without neuropathology had no significant difference. Conclusion. Saliva concentration of Sirt1, Sirt3, Sirt6 assessment in the saliva of long-liver can apply as one of the criteria of molecular early AD diagnostic.
Keywords
Full Text
About the authors
Anastasiia Eduardovna Pukhalskaya
Saint Petersburg Institute of Bioregulation and Gerontology
Author for correspondence.
Email: nastyapuh96@mail.ru
the scientific research of the laboratory of molecular mechanisms of aging
Natalia Sergeevna Linkova
Saint Petersburg Institute of Bioregulation and Gerontology; Academy of postgraduate education underFSBU FSCC of FMBA of Russia; Belgorod National Research University
Email: miayy@yandex.ru
the head of the laboratory of molecular mechanisms of aging; professor of the Department of therapy, geriatrics and antiaging medicine of Academy of postgraduate education; Senior researcher of the Laboratory “Problem of Aging”
Roman Sergeevich Umnov
Saint Petersburg Institute of Bioregulation and Gerontology
Email: t.kmb@mail.ru
the scientific researcher of the Laboratory of Biogerontology of the Department of Biogerontology
Kirill Lenarovich Kozlov
Saint Petersburg Institute of Bioregulation and Gerontology
Email: kozlov_kl@mail.ru
the head of the Department of Clinical Gerontology and Geriatry
Igor Moiseevich Kvetnoy
Saint Petersburg State University; Saint Petersburg Scientific Research Institute of Phthisiopulmonology
Email: info@spbniif.ru
Head of the Center of Molecular Biomedicine; Рrofessor of the Department of Pathology
Mikhail Alexandrovich Paltsev
Moscow State University
Email: mpaltz.ev@gmail.com
Director of Center of Immunology and Molecular Biomedicine
References
- Breijyeh Z., Karaman R.Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020; 25 (24): 5789. https://doi.org/10.3390/molecules25245789.
- Trevisan K., Cristina-Pereira R., Silva-Amaral D., Aversi-Ferreira T.A. Theories of Aging and the Prevalence of Alzheimer's Disease. Biomed. Res.Int. 2019; 2019: 9171424. https://doi.org/10.1155/2019/9171424.
- Lopez O.L., Kuller L.H. Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias. Handb. Clin. Neurol. 2019; 167: 139-48. https://doi.org/10.1016/B978-0-12-804766-8.00009-1.
- Aus6 E., G6mez-Vicente V, Esquiva G. Biomarkers for Alzheimer's Disease Early Diagnosis. J. Pers. Med. 2020; 10 (3): 114. https://doi.org/10.3390/jpm10030114.
- Gleerup H.S., Hasselbalch S.G., Simonsen A.H. Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review. Dis. Markers. 2019; 2019: 4761054. https://doi.org/10.1155/2019/4761054.
- Pukhalskaia A.E., Dyatlova A.S., Linkova N.S., Kozlov K.L., Kvetnaia T.V., Koroleva M.V., Kvetnoy I.M. Sirtuins as possible predictors of aging in Alzheimer's disease development: verification in the hippocampus and saliva. Bull. Exp. Biol. Med. 2020; 106 (6): 821-4. https://doi.org/10.1007/s105.17-020-04986-4
- Pukhalskaia A. E., Linkova N. S., Diatlova A. S., Kozlov K.L., Kvetnoy I. M., Koroleva M. V, Volkov A. M. Sirtuins Expression in the Hippocampus and Buccal Epithelium of Elderly and Senile Individuals with Alzheimer's Disease. Advances in Gerontology. 2021; 11 (2): 126-31. https://doi.org/10.1134/S2079057021020120
- Julien C., Tremblay C., Emond V, Lebbadi M., Salem N. Jr., Bennett D.A., Calon F. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2009; 68 (1): 48-58. https://doi.org/10.1097/NEN.0b013e3181922348
- Koo J.H., Kang E.B., Oh Y.S., Yang D.S., Cho J.Y Treadmill exercise decreases amyloid-p burden possibly via activation of SIRT-1 signaling in a mouse model of Alzheimer's disease. Exp. Neurol. 2017; 288: 142-52. https://doi.org/10.10Wj.expneurol.2016.11.014
- Marwarha G., Raza S., Meiers C., Ghribi O. Leptin attenuates BACE1 expression and amyloid-β genesis via the activation of SIRT1 signaling pathway. Biochim. Biophys. Acta. 2014; 1842 (9): 1587-95. https://doi.org/10.1016/j.bbadis.2014.05.015.
- Lee J., Kim Y, Liu T., Hwang Y.J., Hyeon S.J., Im H., Lee K., Alvarez V.E., McKee A.C., Um S.J., Hur M., Mook-Jung I., Kowall N.W., Ryu H. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease. Aging Cell. 2018; 17 (1): e12679. https://doi.org/10.1111/acel.12679.
- Salvatori I., Valle C., Ferri A., Carri M.T SIRT3 and mitochondrial metabolism in neuro-degenerative diseases. Neurochem.Int. 2017; 109: 184-92. https://doi.org/10.10Wj.neuint.2017.04.012.
- Yin J., Han P., Song M., Nielsen M., Beach T.G., Serrano G.E., Liang W.S., Caselli R.J., Shi J. Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease. Mol. Neurobiol. 2018; 55 (11): 8592-601. https://doi.org/10.1016/j.neuint.2017.04.012.
- Liu Y, Cheng A., Li Y.J., Yang Y., Kishimoto Y, Zhang S., Wang Y., Wan R., Raefsky S.M., Lu D., Saito T, Saido T., Zhu J., Wu L.J., Mattson M.P. SIRT3 mediates hippocampal synaptic adaptations to intermittent fasting and ameliorates deficits in APP mutant mice. Nat.Commun. 2019; 10 (1): 1886. https://doi.org/10.1038/s41467-019-09897-1.
- Cardinale A., de Stefano M.C., Mollinari C., Racaniello M., Garaci E., Merlo D. Biochemical characterization of sirtuin 6 in the brain and its involvement in oxidative stress response. Neurochem. Res. 2015; 40 (1): 59-69. https://doi.org/10.1007/s11064-014-1465-1.
- Braidy N., Poljak A., Grant R., Jayasena T, Mansour H., Chan-Ling T., Smythe G., Sachdev P., Guillemin G.J. Differential expression of sirtuins in the aging rat brain. Front. Cell. Neurosci. 2015; 9: 167. https://doi.org/10.3389/fncel.2015.00167.
- Jung E.S., Choi H., Song H., Hwang Y.J., Kim A., Ryu H., Mook-Jung I. p53-dependent SIRT6 expression protects Ap42-induced DNA damage. Sci. Rep. 2016; 6: 25628. https://doi.org/10.1038/srep25628.
- Kaluski S., Portillo M., Besnard A., Stein D., Einav M., Zhong L., Ueberham U., Arendt T, Mostoslavsky R., Sahay A., Toiber D. Neuroprotective Functions for the Histone Deacetylase SIRT6. Cell Rep. 2017; 18 (13): 3052-62. https://doi.org/10.10Wj.celrep.2017.03.008.
- Tang B.L. Is SIRT6 Activity Neuroprotective and How Does It Differ from SIRT1 in This Regard? Front Cell Neurosci. 2017; 11: 165. https://doi.org/10.3389/fncel.2017.00165.